You can edit almost every page by Creating an account. Otherwise, see the FAQ.

BioDiscovery, Inc.

From EverybodyWiki Bios & Wiki

BioDiscovery, Inc.
Private
ISIN🆔
IndustryComputer software – Genomics Cytogenetics, Human Health
Founded 📆California (1997 (1997))
Founder 👔Soheil Shams[1]
Headquarters 🏙️, ,
Area served 🗺️
Worldwide
Members
Number of employees
🌐 WebsiteBioDiscovery
📇 Address
📞 telephone

BioDiscovery is a scientific software company based in El Segundo, California, focused on genetic research and genomic analysis. Industry peers in 2002 included Silicon Genetics, Omnigon and Geneformatics.[2]

Products[edit]

BioDiscovery's software product consists of three umbrella offerings: Nexus Copy Number (for microarray and NGS copy number analysis), NxClinical (for CNV analysis and visualization), Nexus Expression (for microarray and NGS gene expression) and ImaGene (machine vision microarray analysis).

In addition, the company hosts Nexus DB (using Amazon's AWS as of October 2011), which is a cloud-based collaborative extension to the Nexus product line.

The company's "GeneDirector" software has been described as "a comprehensive microarray data-management solution", including support for workflow processes, sample management and automated image analysis.[3] Software modules support integration with microarray instruments, such as those from Agilent and Affymetrix.[3]

History[edit]

BioDiscovery was founded in 1997 in Los Angeles, California, and has been focused on analyzing data from high-throughput microarrays and next-generation sequencing (NGS). The company's present headquarters are in El Segundo, California.

The company became embroiled in a legal battle with the Canadian firm GSI Lumonics in 1999 over purported breach of contract by GSI in using BioDiscovery trade secrets instantiated in ImaGene software in their own software, with a countersuit by GSI claiming defamation; all litigation was settled in late 2000.[1] This suit began against defendent General Scanning, based in Boston, which had been acquired by GSI Lumonics in March 1999.[4]

In 2002, BioDiscovery was one of seven firms sued by Oxford Gene Technology for unlicensed usage of gene-chip technology invented by Edwin Southan, patented by Oxford in 2000.[5]

In 2014, the company partnered with N-of-One "to provide integrated genomic analysis interpretation solutions", aimed use of genomic data by clinicians.[6]

See also[edit]

References[edit]

  1. 1.0 1.1 "Software wrangling settled". The Ottawa Citizen. Ottawa, Ontario: Southam Publications (CanWest). Canadian Press. November 23, 2000. p. C5 – via Newspapers.com. GSI Lumonics, BioDiscovery end legal actions (sub-title) Unknown parameter |url-status= ignored (help)
  2. Fikes, Bradley J. (July 16, 2002). "Carlsbad company targets biotechs". The Escondido North County Times. 118 (197). Escondido, California. p. D-2 – via Newspapers.com. Unknown parameter |url-status= ignored (help) The cited page is the second of two pages; a link to the first page is here.
  3. Rosenberg, Ronald (December 25, 1999). "Former General Scanning facing copyright lawsuit". The Boston Globe. 256 (178). Boston, Massachusetts: The Globe Newspaper Co. pp. B20, B21 – via Newspapers.com. Unknown parameter |url-status= ignored (help) Second page of article available here.
  4. "Gene Patent Lawsuit Names Five California Firms". Los Angeles Times. CXXII (24) (Orange County ed.). Tribune Publishing Company. Bloomberg. December 27, 2002. p. B6 – via Newspapers.com. Unknown parameter |url-status= ignored (help)
  5. Staff (March 25, 2014). "BioDiscovery, N-of-One Partner to Deliver Genomic Analysis Platform". Genetic Engineering & Biotechnology News. Mary Ann Liebert. Retrieved 21 Dec 2019. Unknown parameter |url-status= ignored (help)

Further reading[edit]


This article "BioDiscovery" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:BioDiscovery. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.